Kardiale Erkrankungen

  • Brigitte Stiller


Kritische angeborene strukturelle Herzfehler können duktusabhängig sein und sollten vom Neonatologen frühzeitig erkannt werden. Das Kapitel beschreibt diese Herzfehler in Symptomatik, Diagnostik und Therapie und beinhaltet anschauliche Zeichnungen der für die Neugeborenenperiode relevanten Herzfehler. Ferner werden Hyper- und Hypotonus ebenso wie die klinisch relevanten Herzrhythmusstörungen und die Intensivbehandlung der Herzinsuffizienz dargestellt.


  1. 1.
    (1997) The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl J Med 336(8):525–33Google Scholar
  2. 2.
    (1999) Systolic blood pressure in babies of less than 32 weeks gestation in the first year of life. Northern Neonatal Nursing Initiative. Arch Dis Child Fetal Neonatal Ed 80(1):F38–42Google Scholar
  3. 3.
    Ahlfors CE (2004) Effect of ibuprofen on bilirubin-albumin binding. J Pediatr 144(3):386–8Google Scholar
  4. 4.
    Alabed S, Sabouni A, Al Dakhoul S, Bdaiwi Y, Frobel-Mercier AK (2016) Beta-blockers for congestive heart failure in children. The Cochrane database of systematic reviews. (1):CD007037Google Scholar
  5. 5.
    Alwi M, Choo KK, Latiff HA, Kandavello G, Samion H, Mulyadi MD (2004) Initial results and medium-term follow-up of stent implantation of patent ductus arteriosus in duct-dependent pulmonary circulation. J Am Coll Cardiol 44(2):438–45Google Scholar
  6. 6.
    Arlettaz R, Bauschatz AS, Monkhoff M, Essers B, Bauersfeld U (2006) The contribution of pulse oximetry to the early detection of congenital heart disease in newborns. Eur J Pediatr 165(2):94–8Google Scholar
  7. 7.
    Bahrami KR, Van Meurs KP (2005) ECMO for neonatal respiratory failure. Semin Perinatol 29(1):15–23Google Scholar
  8. 8.
    Bailey JM, Hoffman TM, Wessel DL, Nelson DP, Atz AM, Chang AC, Kulik TJ, Spray TL, Akbary A, Miller RP, Wernovsky G (2004) A population pharmacokinetic analysis of milrinone in pediatric patients after cardiac surgery. J Pharmacokinet Pharmacodyn 31(1):43–59Google Scholar
  9. 9.
    Balaguru D, Auslender M (2000) Vasodilators in the treatment of pediatric heart failure. Prog Pediatr Cardiol 12(1):81–90Google Scholar
  10. 10.
    Ballweg JA, Dominguez TE, Ravishankar C, Gaynor JW, Nicolson SC, Spray TL, Tabbutt S A contemporary comparison of the effect of shunt type in hypoplastic left heart syndrome on the hemodynamics and outcome at Fontan completion. J Thorac Cardiovasc Surg 140(3):537–44Google Scholar
  11. 11.
    Barbaro RP, Bartlett RH, Chapman RL, Paden ML, Roberts LA, Gebremariam A, Annich GM, Davis MM (2016) Development and Validation of the Neonatal Risk Estimate Score for Children Using Extracorporeal Respiratory Support. The Journal of pediatrics 173:56–61 e3Google Scholar
  12. 12.
    Barrington KJ, Finer NN (2007) Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev. (3):CD000509Google Scholar
  13. 13.
    Bassler D, Choong K, McNamara P, Kirpalani H (2006) Neonatal persistent pulmonary hypertension treated with milrinone: four case reports. Biology of the neonate 89(1):1–5Google Scholar
  14. 14.
    Bassler D, Kreutzer K, McNamara P, Kirpalani H (2010) Milrinone for persistent pulmonary hypertension of the newborn. The Cochrane database of systematic reviews. (11):CD007802Google Scholar
  15. 15.
    Bell E, Acarregui M (2001) Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. The Cochrane Database of Dystematic Reviews. (3):CD000503Google Scholar
  16. 16.
    Bhayat SI, Gowda HM, Eisenhut M (2016) Should dopamine be the first line inotrope in the treatment of neonatal hypotension? Review of the evidence. World journal of clinical pediatrics 5(2):212–22Google Scholar
  17. 17.
    Bowles NE, Ni J, Kearney DL, Pauschinger M, Schultheiss HP, McCarthy R, Hare J, Bricker JT, Bowles KR, Towbin JA (2003) Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 42(3):466–72Google Scholar
  18. 18.
    Brown JW, Park HJ, Turrentine MW (2001) Arterial switch operation: factors impacting survival in the current era. Ann Thorac Surg 71(6):1978–84Google Scholar
  19. 19.
    Brown KL, Miles F, Sullivan ID, Hoskote A, Verhulst L, Ridout DA, Goldman AP (2005) Outcome in neonates with congenital heart disease referred for respiratory extracorporeal membrane oxygenation. Acta Paediatr 94(9):1280–4Google Scholar
  20. 20.
    Buck ML (2005) Clinical experience with spironolactone in pediatrics. Ann Pharmacother 39(5):823–8Google Scholar
  21. 21.
    Capomolla S, Febo O, Opasich C, Guazzotti G, Caporotondi A, La Rovere MT, Gnemmi M, Mortara A, Vona M, Pinna GD, Maestri R, Cobelli F (2001) Chronic infusion of dobutamine and nitroprusside in patients with end-stage heart failure awaiting heart transplantation: safety and clinical outcome. Eur J Heart Fail 3(5):601–10Google Scholar
  22. 22.
    Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA (2006) Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 354(6):579–87Google Scholar
  23. 23.
    Channer K, McLean K, al e (1994) Combination diuretic treatment in severe heart failure: a randomised controlled trial. Br Heart J 71:146–50Google Scholar
  24. 24.
    Cooke L, Steer P, Woodgate P (2003) Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. The Cochrane Database of Systematic Reviews.CD003745Google Scholar
  25. 25.
    Cornfield DN, Maynard RC, deRegnier RA, Guiang SF, 3rd, Barbato JE, Milla CE (1999) Randomized, controlled trial of low-dose inhaled nitric oxide in the treatment of term and near-term infants with respiratory failure and pulmonary hypertension. Pediatrics 104(5 Pt 1):1089–94Google Scholar
  26. 26.
    Crochemore C, Lu J, Wu Y, Liposits Z, Sousa N, Holsboer F, Almeida OF (2005) Direct targeting of hippocampal neurons for apoptosis by glucocorticoids is reversible by mineralocorticoid receptor activation. Mol Psychiatry 10(8):790–8Google Scholar
  27. 27.
    Crosson JE, Etheridge SP, Milstein S, Hesslein PS, Dunnigan A (1994) Therapeutic and diagnostic utility of adenosine during tachycardia evaluation in children. Am J Cardiol 74(2):155–60Google Scholar
  28. 28.
    Dalton HJ, Rycus PT, Conrad SA (2005) Update on extracorporeal life support 2004. Semin Perinatol 29(1):24–33Google Scholar
  29. 29.
    de Lagausie P, de Buys-Roessingh A, Ferkdadji L, Saada J, Aisenfisz S, Martinez-Vinson C, Fund X, Cayuela JM, Peuchmaur M, Mercier JC, Berrebi D (2005) Endothelin receptor expression in human lungs of newborns with congenital diaphragmatic hernia. J Pathol 205(1):112–8Google Scholar
  30. 30.
    Deloof E, Devlieger H, Van Hoestenberghe R, Van den berghe K, Daenen W, Gewillig M (1997) Management with a staged approach of the premature hydropic fetus due to complete congenital heart block. Eur J Pediatr 156(7):521–3Google Scholar
  31. 31.
    Dodge-Khatami A, Ott S, Di Bernardo S, Berger F (2005) Carotid-subclavian artery index: new echocardiographic index to detect coarctation in neonates and infants. The Annals of thoracic surgery 80(5):1652–7Google Scholar
  32. 32.
    Dorostkar PC, Arko MK, Baird TM, Rodriguez S, Martin RJ (2005) Asystole and severe bradycardia in preterm infants. Biol Neonate 88(4):299–305Google Scholar
  33. 33.
    Duggal B, Pratap U, Slavik Z, Kaplanova J, Macrae D (2005) Milrinone and low cardiac output following cardiac surgery in infants: is there a direct myocardial effect? Pediatr Cardiol 26(5):642–5Google Scholar
  34. 34.
    Duncan BW, Bohn DJ, Atz AM, French JW, Laussen PC, Wessel DL (2001) Mechanical circulatory support for the treatment of children with acute fulminant myocarditis. The Journal of thoracic and cardiovascular surgery 122(3):440–8Google Scholar
  35. 35.
    Etheridge SP, Craig JE, Compton SJ (2001) Amiodarone is safe and highly effective therapy for supraventricular tachycardia in infants. Am Heart J 141(1):105–10Google Scholar
  36. 36.
    Evans N, Iyer P (1993) Change in blood pressure after treatment of patent ductus arteriosus with indomethacin. Arch Dis Child 68(5 Spec No):584–7Google Scholar
  37. 37.
    Evans N, Kluckow M, Simmons M, Osborn D (2002) Which to measure, systemic or organ blood flow? Middle cerebral artery and superior vena cava flow in very preterm infants. Arch Dis Child Fetal Neonatal Ed 87(3):F181–4Google Scholar
  38. 38.
    Evans N, Osborn D, Kluckow M (2005) Preterm circulatory support is more complex than just blood pressure. Pediatrics 115(4):1114–5; author reply 5–6Google Scholar
  39. 39.
    Finer NN, Barrington KJ (2001) Nitric oxide for respiratory failure in infants born at or near term. The Cochrane database of systematic reviews. (2):CD000399Google Scholar
  40. 40.
    Finer NN, Barrington KJ (2006) Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev. (4):CD000399Google Scholar
  41. 41.
    Fowlie P, Davis P (2002) Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. The Cochrane Database of Systematic Review. (3):CD000174Google Scholar
  42. 42.
    Garty Y, Veldtman G, Lee K, Benson L (2005) Late outcomes after pulmonary valve balloon dilatation in neonates, infants and children. J Invasive Cardiol 17(6):318–22Google Scholar
  43. 43.
    Glass P, Wagner AE, Papero PH, Rajasingham SR, Civitello LA, Kjaer MS, Coffman CE, Getson PR, Short BL (1995) Neurodevelopmental status at age five years of neonates treated with extracorporeal membrane oxygenation. J Pediatr 127(3):447–57Google Scholar
  44. 44.
    Glen S, Burns J, Bloomfield P (2004) Prevalence and development of additional cardiac abnormalities in 1448 patients with congenital ventricular septal defects. Heart 90(11):1321–5Google Scholar
  45. 45.
    Goldberg CS, Gomez CA (2003) Hypoplastic left heart syndrome: new developments and current controversies. Semin Neonatol 8(6):461–8Google Scholar
  46. 46.
    Goldmuntz E (2005) DiGeorge syndrome: new insights. Clin Perinatol 32(4):963–78, ix-xGoogle Scholar
  47. 47.
    Habib DM, Padbury JF, Anas NG, Perkin RM, Minegar C (1992) Dobutamine pharmacokinetics and pharmacodynamics in pediatric intensive care patients. Crit Care Med 20(5):601–8Google Scholar
  48. 48.
    Hardart GE, Hardart MK, Arnold JH (2004) Intracranial hemorrhage in premature neonates treated with extracorporeal membrane oxygenation correlates with conceptional age. J Pediatr 145(2):184–9Google Scholar
  49. 49.
    Hausdorf G (2000) Intensivtherapie angeborener Herzfehler, Steinkopff Verlag: DarmstadtGoogle Scholar
  50. 50.
    Hawkins JA, Minich LL, Tani LY, Day RW, Judd VE, Shaddy RE, McGough EC (1998) Late results and reintervention after aortic valvotomy for critical aortic stenosis in neonates and infants. Ann Thorac Surg 65(6):1758–62; discussion 63Google Scholar
  51. 51.
    Hebra A, Brown MF, Hirschl RB, McGeehin K, O’Neill JA, Jr., Norwood WI, Ross AJ, 3rd (1993) Mesenteric ischemia in hypoplastic left heart syndrome. J Pediatr Surg 28(4):606–11Google Scholar
  52. 52.
    Herrera C, Holberton J, Davis P (2007) Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev. (2):CD003480Google Scholar
  53. 53.
    Hoffman GM, Ross GA, Day SE, Rice TB, Nelin LD (1997) Inhaled nitric oxide reduces the utilization of extracorporeal membrane oxygenation in persistent pulmonary hypertension of the newborn. Crit Care Med 25(2):352–9Google Scholar
  54. 54.
    Hoffman TM, Wernovsky G, Atz AM, Kulik TJ, Nelson DP, Chang AC, Bailey JM, Akbary A, Kocsis JF, Kaczmarek R, Spray TL, Wessel DL (2003) Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 107(7):996–1002Google Scholar
  55. 55.
    Howard LS, Morrell NW (2005) New therapeutic agents for pulmonary vascular disease. Paediatr Respir Rev 6(4):285–91Google Scholar
  56. 56.
    Iyer P, Evans N (1994) Re-evaluation of the left atrial to aortic root ratio as a marker of patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 70(2):F112–7Google Scholar
  57. 57.
    Juliana AE, Abbad FC (2005) Severe persistent pulmonary hypertension of the newborn in a setting where limited resources exclude the use of inhaled nitric oxide: successful treatment with sildenafil. Eur J Pediatr 164(10):626–9Google Scholar
  58. 58.
    Kelley J (1986) Digoxinreceptors in the neonate. In: Pediatric cardiology, EF D, MA E, WM G, WJ R, (eds.), p. 1233 ff, Springer: Berlin Heidelberg New York TokyoGoogle Scholar
  59. 59.
    Kinsella JP, Abman SH (1997) Inhaled nitric oxide in the premature infant: animal models and clinical experience. Semin Perinatol 21(5):418–25Google Scholar
  60. 60.
    Kinsella JP, Truog WE, Walsh WF, Goldberg RN, Bancalari E, Mayock DE, Redding GJ, deLemos RA, Sardesai S, McCurnin DC, Moreland SG, Cutter GR, Abman SH (1997) Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. The Journal of pediatrics 131(1 Pt 1):55–62Google Scholar
  61. 61.
    Kluckow M, Evans N (1995) Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr 127(5):774–9Google Scholar
  62. 62.
    Koehne P, Rüdiger M (2005) Persistierender Ductus arteriosus des Frühgeborenen. In: Evidenz- basierte Pädiatrie, Ergänzungswerk 1, Bassler D, Forster J, Antes G, (eds.), pp. 1–28, ThiemeGoogle Scholar
  63. 63.
    Kostelka M, Walther T, Geerdts I, Rastan A, Jacobs S, Dahnert I, Kiefer H, Bellinghausen W, Mohr FW (2004) Primary repair for aortic arch obstruction associated with ventricular septal defect. Ann Thorac Surg 78(6):1989–93; discussion 93Google Scholar
  64. 64.
    Lakshminrusimha S, Saugstad OD (2016) The fetal circulation, pathophysiology of hypoxemic respiratory failure and pulmonary hypertension in neonates, and the role of oxygen therapy. Journal of perinatology : official journal of the California Perinatal Association 36 Suppl 2:S3-S11Google Scholar
  65. 65.
    Latifi S, Lidsky K, Blumer JL (2000) Pharmacology of inotropic agents in infants and children. Prog Pediatr Cardiol 12(1):57–79Google Scholar
  66. 66.
    Lewis A, Freed M, Heymann M, Roehl S, Kinsey R (1981) Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease. Circulation 64:893–8Google Scholar
  67. 67.
    Lin HC, Su BH, Lin TW, Tsai CH, Yeh TF (2005) System-based strategy for the management of meconium aspiration syndrome: 198 consecutive cases observations. Acta Paediatr Taiwan 46(2):67–71Google Scholar
  68. 68.
    Lindinger A, Schwedler G, Hense HW Prevalence of Congenital Heart Defects in Newborns in Germany: Results of the First Registration Year of the PAN Study (July 2006 to June 2007). Klin PadiatrGoogle Scholar
  69. 69.
    Long W (1990) Fetal and neonatal cardiology, Saunders: PhiladelphiaGoogle Scholar
  70. 70.
    Luciani GB, Nichani S, Chang AC, Wells WJ, Newth CJ, Starnes VA (1997) Continuous versus intermittent furosemide infusion in critically ill infants after open heart operations. Ann Thorac Surg 64(4):1133–9Google Scholar
  71. 71.
    Mahle WT, Spray TL, Wernovsky G, Gaynor JW, Clark BJ, 3rd (2000) Survival after reconstructive surgery for hypoplastic left heart syndrome: A 15-year experience from a single institution. Circulation 102(19 Suppl 3):III136–41Google Scholar
  72. 72.
    Malviya M, Ohlsson A, Shah S (2003) Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev. (3):CD003951Google Scholar
  73. 73.
    Marmon LM, Bye MR, Haas JM, Balsara RK, Dunn JM (1984) Vascular rings and slings: long-term follow-up of pulmonary function. J Pediatr Surg 19(6):683–92Google Scholar
  74. 74.
    McCarthy RE, 3rd, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, Baughman KL (2000) Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 342(10):690–5Google Scholar
  75. 75.
    McCrindle BW (2005) Is balloon aortic valvuloplasty a feasible treatment for neonates and young infants with aortic valve stenosis? Nat Clin Pract Cardiovasc Med 2(7):340–1Google Scholar
  76. 76.
    McElhinney DB, Hedrick HL, Bush DM, Pereira GR, Stafford PW, Gaynor JW, Spray TL, Wernovsky G (2000) Necrotizing enterocolitis in neonates with congenital heart disease: risk factors and outcomes. Pediatrics 106(5):1080–7Google Scholar
  77. 77.
    Michalsky MP, Arca MJ, Groenman F, Hammond S, Tibboel D, Caniano DA (2005) Alveolar capillary dysplasia: a logical approach to a fatal disease. J Pediatr Surg 40(7):1100–5Google Scholar
  78. 78.
    Mirochnick MH, Miceli JJ, Kramer PA, Chapron DJ, Raye JR (1988) Furosemide pharmacokinetics in very low birth weight infants. J Pediatr 112(4):653–7Google Scholar
  79. 79.
    Mugford M, Elbourne D, Field D (2008) Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants. Cochrane Database Syst Rev. (3):CD001340Google Scholar
  80. 80.
    Munro MJ, Walker AM, Barfield CP (2004) Hypotensive extremely low birth weight infants have reduced cerebral blood flow. Pediatrics 114(6):1591–6Google Scholar
  81. 81.
    Neches W, Park S, Ettedgui J (1997) Tetralogy of Fallot and Tetralogy of Fallot with Pulmonary Atresia. In: The science and practice of pediatric cardiology, Garson A, Bricker JT, Fisher D, Neish S, (eds.), p. 1400, Williams and WilkinsGoogle Scholar
  82. 82.
    Obladen M, Koehne B (2004) Interventions for Persisting Ductus Arteriosus in the Preterm Infant, Springer HeidelbergGoogle Scholar
  83. 83.
    Ohlsson A, Walia R, Shah SS (2015) Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. The Cochrane database of systematic reviews. (2):CD003481Google Scholar
  84. 84.
    Ohye RG, Gomez CA, Ohye BJ, Goldberg CS, Bove EL (2001) The Ross/Konno procedure in neonates and infants: intermediate-term survival and autograft function. Ann Thorac Surg 72(3):823–30Google Scholar
  85. 85.
    Ohye RG, Sleeper LA, Mahony L, Newburger JW, Pearson GD, Lu M, Goldberg CS, Tabbutt S, Frommelt PC, Ghanayem NS, Laussen PC, Rhodes JF, Lewis AB, Mital S, Ravishankar C, Williams IA, Dunbar-Masterson C, Atz AM, Colan S, Minich LL, Pizarro C, Kanter KR, Jaggers J, Jacobs JP, Krawczeski CD, Pike N, McCrindle BW, Virzi L, Gaynor JW Comparison of shunt types in the Norwood procedure for single-ventricle lesions. N Engl J Med 362(21):1980–92Google Scholar
  86. 86.
    Osborn DA, Evans N (2004) Early volume expansion for prevention of morbidity and mortality in very preterm infants. Cochrane Database Syst Rev. (2):CD002055Google Scholar
  87. 87.
    Paradisis M, Osborn DA (2004) Adrenaline for prevention of morbidity and mortality in preterm infants with cardiovascular compromise. Cochrane Database Syst Rev. (1):CD003958Google Scholar
  88. 88.
    Park Y, Lucas VW, Sklansky MS, Kashani IA, Rothman A (1997) Balloon angioplasty of native aortic coarctation in infants 3 months of age and younger. Am Heart J 134(5 Pt 1):917–23Google Scholar
  89. 89.
    Pass RH, Hijazi Z, Hsu DT, Lewis V, Hellenbrand WE (2004) Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one-year results. J Am Coll Cardiol 44(3):513–9Google Scholar
  90. 90.
    Paul T, Bertram H, Kriebel T, Windhagen-Mahnert B, Tebbenjohanns J, Hausdorf G (2000) Supraventrikuläre tachykardien bei Säuglingen, Kindern und Jugendlichen: Diagnostik-Medikamentöse und interventionelle Therapie. Z Kardiol 89:546–58Google Scholar
  91. 91.
    Paul T, Pfammatter JP (1997) Adenosine: an effective and safe antiarrhythmic drug in pediatrics. Pediatr Cardiol 18(2):118–26Google Scholar
  92. 92.
    Pellicer A, Valverde E, Elorza MD, Madero R, Gaya F, Quero J, Cabanas F (2005) Cardiovascular support for low birth weight infants and cerebral hemodynamics: a randomized, blinded, clinical trial. Pediatrics 115(6):1501–12Google Scholar
  93. 93.
    Pfammatter JP, Stocker FP (1998) Results of a restrictive use of antiarrhythmic drugs in the chronic treatment of atrioventricular reentrant tachycardias in infancy and childhood. Am J Cardiol 82(1):72–5Google Scholar
  94. 94.
    Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341(10):709–17Google Scholar
  95. 95.
    Reynolds EW, Ellington JG, Vranicar M, Bada HS (2004) Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn. Pediatrics 114(5):1297–304Google Scholar
  96. 96.
    Rimensberger PC, Spahr-Schopfer I, Berner M, Jaeggi E, Kalangos A, Friedli B, Beghetti M (2001) Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms. Circulation 103(4):544–8Google Scholar
  97. 97.
    Roberts JD, Jr., Fineman JR, Morin FC, 3rd, Shaul PW, Rimar S, Schreiber MD, Polin RA, Zwass MS, Zayek MM, Gross I, Heymann MA, Zapol WM (1997) Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med 336(9):605–10Google Scholar
  98. 98.
    Rosati E, Chitano G, Dipaola L, De Felice C, Latini G (2005) Indications and limitations for a neonatal pulse oximetry screening of critical congenital heart disease. J Perinat Med 33(5):455–7Google Scholar
  99. 99.
    Roy DL, McIntyre L, Human DG, Nanton MA, Sherman GJ, Allen LM, Finley JP (1994) Trends in the prevalence of congenital heart disease: comprehensive observations over a 24-year period in a defined region of Canada. Can J Cardiol 10(8):821–6Google Scholar
  100. 100.
    Sadiq HF, Mantych G, Benawra RS, Devaskar UP, Hocker JR (2003) Inhaled nitric oxide in the treatment of moderate persistent pulmonary hypertension of the newborn: a randomized controlled, multicenter trial. Journal of perinatology: official journal of the California Perinatal Association 23(2):98–103Google Scholar
  101. 101.
    Saul JP, Walsh EP, Triedman JK (1995) Mechanisms and therapy of complex arrhythmias in pediatric patients. J Cardiovasc Electrophysiol 6(12):P1129–48Google Scholar
  102. 102.
    Shah PS, Ohlsson A (2007) Sildenafil for pulmonary hypertension in neonates. Cochrane Database Syst Rev. (3):CD005494Google Scholar
  103. 103.
    Shah S, Ohlsson A (2006) Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev. (1):CD004213Google Scholar
  104. 104.
    Shann F (2008) Drug doses. 14 Edition, Collective Pty Ltd: Parkville AustraliaGoogle Scholar
  105. 105.
    Shinkawa T, Bove EL, Hirsch JC, Devaney EJ, Ohye RG (2010) Intermediate-term results of the Ross procedure in neonates and infants. Ann Thorac Surg 89(6):1827–32; discussion 32Google Scholar
  106. 106.
    Simons SH, van Dijk M, van Lingen RA, Roofthooft D, Boomsma F, van den Anker JN, Tibboel D (2005) Randomised controlled trial evaluating effects of morphine on plasma adrenaline/noradrenaline concentrations in newborns. Arch Dis Child Fetal Neonatal Ed 90(1):F36–40Google Scholar
  107. 107.
    Skinner J, Alverson D, Hunter S (2000) Echocardiography for the neonatologist, Churchill Livingstone ElsevierGoogle Scholar
  108. 108.
    Spillers J (2010) PPHN: is sildenafil the new nitric? A review of the literature. Adv Neonatal Care 10(2):69–74Google Scholar
  109. 109.
    Steinhorn RH (2016) Advances in Neonatal Pulmonary Hypertension. Neonatology 109(4):334–44Google Scholar
  110. 110.
    Steinhorn RH, Cox PN, Fineman JR, Finer NN, Rosenberg EM, Silver MM, Tyebkhan J, Zwass MS, Morin FC, 3rd (1997) Inhaled nitric oxide enhances oxygenation but not survival in infants with alveolar capillary dysplasia. The Journal of pediatrics 130(3):417–22Google Scholar
  111. 111.
    Stiller B, Dähnert I, Weng Y, Hennig E, Hetzer R, Lange P (1999) Children may survive severe myocarditis with prolonged use of biventricular assist devices. Heart 82:237–40Google Scholar
  112. 112.
    Stiller B, Hetzer R, Weng Y, Hummel M, Hennig E, Nagdyman N, Ewert P, Lehmkuhl H, Lange P (2003) Heart transplantation in children after mechanical circulatory support with pulsatile pneumatic assist device. J Heart Lung Transplant 22:1201–8Google Scholar
  113. 113.
    Stiller B, Lemmer J, Merkle F, Alexi-Meskishvili V, Weng Y, Hübler M, Koster A, Drews T, Lange P, Hetzer R (2004) Consumption of blood products during mechanical circulatory support in children: comparison between ECMO and a pulsatile ventricular assist device. Intensive Care Medicine 30:1814–20Google Scholar
  114. 114.
    Stiller B, Weng Y, Hubler M, Lemmer J, Nagdyman N, Redlin M, Lange P, Hetzer R (2005) Pneumatic pulsatile ventricular assist devices in children under 1 year of age. Eur J Cardiothorac SurgGoogle Scholar
  115. 115.
    Subhedar N, Shaw N (2006) Dopamine versus dobutamine for hypotensive preterm infants. The Cochrane Database of Systematic Reviews. (1)Google Scholar
  116. 116.
    Subhedar NV, Shaw NJ (2003) Dopamine versus dobutamine for hypotensive preterm infants. Cochrane Database Syst Rev. (3):CD001242Google Scholar
  117. 117.
    Tanner K, Sabrine N, Wren C (2005) Cardiovascular malformations among preterm infants. Pediatrics 116(6):e833–8Google Scholar
  118. 118.
    Tautz J, Merkel C, Loersch F, Egen O, Hagele F, Thon HM, Schaible T (2010) Implication of pulse oxymetry screening for detection of congenital heart defects. Klinische Padiatrie 222(5):291–5Google Scholar
  119. 119.
    Thompson RB, van den Bos EJ, Esposito DJ, Owen CH, Glower DD (2003) The effects of acute afterload change on systolic ventricular function in conscious dogs with normal vs. failing hearts. Eur J Heart Fail 5(6):741–9Google Scholar
  120. 120.
    Tibballs J, Chow CW (2002) Incidence of alveolar capillary dysplasia in severe idiopathic persistent pulmonary hypertension of the newborn. J Paediatr Child Health 38(4):397–400Google Scholar
  121. 121.
    Tobler D, Williams WG, Jegatheeswaran A, Van Arsdell GS, McCrindle BW, Greutmann M, Oechslin EN, Silversides CK (2010) Cardiac outcomes in young adult survivors of the arterial switch operation for transposition of the great arteries. J Am Coll Cardiol 56(1):58–64Google Scholar
  122. 122.
    Travadi JN, Patole SK (2003) Phosphodiesterase inhibitors for persistent pulmonary hypertension of the newborn: a review. Pediatr Pulmonol 36(6):529–35Google Scholar
  123. 123.
    Ward K, Mullins C (1997) Anomalous pulmonary venous connections, vein stenosis, and atresia of the common vein. In: The science and practice of pediatric cardiology, Garson A, Bricker JT, Fisher D, Neish S, (eds.), pp. 1431–45Google Scholar
  124. 124.
    Wedgwood S, Black SM (2005) Endothelin-1 decreases endothelial NOS expression and activity through ETA receptor-mediated generation of hydrogen peroxide. Am J Physiol Lung Cell Mol Physiol 288(3):L480–7Google Scholar
  125. 125.
    Weinberger B, Weiss K, Heck DE, Laskin DL, Laskin JD (2001) Pharmacologic therapy of persistent pulmonary hypertension of the newborn. Pharmacol Ther 89(1):67–79Google Scholar
  126. 126.
    Wernovsky G, Ghanayem N, Ohye RG, Bacha EA, Jacobs JP, Gaynor JW, Tabbutt S (2007) Hypoplastic left heart syndrome: consensus and controversies in 2007. Cardiol Young 17 Suppl 2:75–86Google Scholar
  127. 127.
    Wetter J, Belli E, Sinzobahamvya N, Blaschzok HC, Brecher AM, Urban AE (2001) Transposition of the great arteries associated with ventricular septal defect: surgical results and long-term outcome. Eur J Cardiothorac Surg 20(4):816–23Google Scholar
  128. 128.
    Wood AE, Javadpour H, Duff D, Oslizlok P, Walsh K (2004) Is extended arch aortoplasty the operation of choice for infant aortic coarctation? Results of 15 years’ experience in 181 patients. Ann Thorac Surg 77(4):1353–7; discussion 7–8Google Scholar
  129. 129.
    Yerebakan C, Valeske K, Elmontaser H, Yoruker U, Mueller M, Thul J, Mann V, Latus H, Villanueva A, Hofmann K, Schranz D, Akintuerk H (2016) Hybrid therapy for hypoplastic left heart syndrome: Myth, alternative, or standard? The Journal of thoracic and cardiovascular surgery 151(4):1112–21, 23 e1–5Google Scholar
  130. 130.
    Adelman RD (1988) The hypertensive neonate. Clin Perinatol 15: 567–85Google Scholar

Copyright information

© Springer-Verlag GmbH Deutschland 2017

Authors and Affiliations

  • Brigitte Stiller
    • 1
  1. 1.Klinik für Angeborene Herzfehler und Pädiatrische KardiologieUniversitäts Herzzentrum Freiburg Bad KrozingenFreiburg

Personalised recommendations